Clovis Oncology reported $28.44M in Gross Profit on Sales for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 110.02M 8.15M
Agenus AGEN:US $ 10.06M 551K
Anika Therapeutics ANIK:US $ 20.81M 0.16M
AstraZeneca AZN:LN 6.03B 627M
Astrazeneca AZN:US 6.03B 627M
Eli Lilly And LLY:US $ 4786.9M 140.1M
Esperion Therapeutics ESPR:US $ 38.86M 32.66M
GlaxoSmithKline GSK:LN 5.57B 566M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Halozyme Therapeutics HALO:US $ 113.44M 42.63M
Heron Therapeutics HRTX:US $ 7.92M 2.89M
Insmed INSM:US $ 34.53M 4.16M
Ligand Pharmaceuticals LGND:US $ 54.08M 7.08M
Merk MRK:US $ 8718M 93M
Neurocrine Biosciences NBIX:US $ 285.8M 52.1M
Novartis NOVN:VX 9.54B 679M
Pfizer PFE:US $ 11985M 1575M
Puma Biotechnology PBYI:US $ 41.42M 27.2M
Rigel Pharmaceuticals RIGL:US $ 26.14M 54.56M
Seattle Genetics SGEN:US $ 310.39M 42.54M
Ultragenyx Pharmaceutical RARE:US $ 83.84M 10.37M
Veracyte VCYT:US $ 37.63M 13.33M
YTE INCY:US $ 673.08M 92.18M